Clinical Trials Sponsored by Flamingo Therapeutics NV

Total 8 results

Flamingo Therapeutics NV

Recruiting

Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC (PEMDA-HN)

HNSCC

United States, Korea, Republic of
Montefiore Medical Center
M.D. Anderson Cancer Center; Flamingo Therapeutics NV

Recruiting

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Acute Myeloid Leukemia | Myelodysplastic Syndromes | AML/MDS

United States
Origo Biopharma

Completed

First in Human Study of ORG-129 in Healthy Volunteers

Healthy Volunteers

Spain
Agomab Spain S.L.

Recruiting

STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Fibrostenotic Crohn's Disease

United States, Italy, Poland, Spain, Denmark, Austria, Canada, Germany
Agomab Spain S.L.

Completed

Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

Healthy Volunteers

Belgium
Agomab Spain S.L.

Completed

Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

Healthy Volunteers

Belgium
Agomab Spain S.L.

Recruiting

Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

IPF

United Kingdom
Atriva Therapeutics GmbH
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ATR-002

Influenza

Belgium

3

Subscribe